These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 36001424)
1. Betel quid: New insights into an ancient addiction. Stokes C; Pino JA; Hagan DW; Torres GE; Phelps EA; Horenstein NA; Papke RL Addict Biol; 2022 Sep; 27(5):e13223. PubMed ID: 36001424 [TBL] [Abstract][Full Text] [Related]
2. Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds. Horenstein NA; Quadri M; Stokes C; Shoaib M; Papke RL Nicotine Tob Res; 2019 May; 21(6):805-812. PubMed ID: 29059390 [TBL] [Abstract][Full Text] [Related]
3. Nicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and Anti-Inflammatory Activity. Papke RL; Horenstein NA; Stokes C PLoS One; 2015; 10(10):e0140907. PubMed ID: 26488401 [TBL] [Abstract][Full Text] [Related]
4. Betel Nut (areca) and Smokeless Tobacco Use in Myanmar. Papke RL; Bhattacharyya I; Hatsukami DK; Moe I; Glatman S Subst Use Misuse; 2020; 55(9):1385-1394. PubMed ID: 31220988 [No Abstract] [Full Text] [Related]
5. Betel quid dependence mechanism and potential cessation therapy. Ko AM; Lee CH; Ko AM; Ko YC Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109982. PubMed ID: 32454163 [TBL] [Abstract][Full Text] [Related]
6. Intoxication and substance use disorder to Areca catechu nut containing betel quid: A review of epidemiological evidence, pharmacological basis and social factors influencing quitting strategies. Osborne PG; Ko YC; Wu MT; Lee CH Drug Alcohol Depend; 2017 Oct; 179():187-197. PubMed ID: 28787696 [TBL] [Abstract][Full Text] [Related]
7. Toxicity of areca nut ingredients: activation of CHK1/CHK2, induction of cell cycle arrest, and regulation of MMP-9 and TIMPs production in SAS epithelial cells. Chang MC; Chan CP; Wang WT; Chang BE; Lee JJ; Tseng SK; Yeung SY; Hahn LJ; Jeng JH Head Neck; 2013 Sep; 35(9):1295-302. PubMed ID: 22907745 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of the areca alkaloids - toxic and psychoactive constituents of the areca (betel) nut. Myers AL Drug Metab Rev; 2022 Nov; 54(4):343-360. PubMed ID: 35543097 [TBL] [Abstract][Full Text] [Related]
10. Integrated metabolomics and network pharmacology to reveal the mechanism of areca nut addiction. Li M; Pang X; Guo Z; Yang Y; Gu Z; Zhang L Addict Biol; 2023 Dec; 28(12):e13352. PubMed ID: 38017647 [TBL] [Abstract][Full Text] [Related]
11. A study of betel quid carcinogenesis. 1. On the in vitro N-nitrosation of arecoline. Wenke G; Hoffmann D Carcinogenesis; 1983; 4(2):169-72. PubMed ID: 6825205 [TBL] [Abstract][Full Text] [Related]
12. Pilot study of the pharmacokinetics of betel nut and betel quid biomarkers in saliva, urine, and hair of betel consumers. Franke AA; Li X; Lai JF Drug Test Anal; 2016 Oct; 8(10):1095-1099. PubMed ID: 26619803 [TBL] [Abstract][Full Text] [Related]
14. DARK Classics in Chemical Neuroscience: Arecoline. Volgin AD; Bashirzade A; Amstislavskaya TG; Yakovlev OA; Demin KA; Ho YJ; Wang D; Shevyrin VA; Yan D; Tang Z; Wang J; Wang M; Alpyshov ET; Serikuly N; Wappler-Guzzetta EA; Lakstygal AM; Kalueff AV ACS Chem Neurosci; 2019 May; 10(5):2176-2185. PubMed ID: 30664352 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic Effects of Betel Quid and Areca Nut Aqueous Extracts on Mouse Fibroblast, Human Mouth-Ordinary-Epithelium 1 and Human Oral Squamous Cell Carcinoma Cell Lines. Al-Tayar BA; Ahmad A; Yusoff ME; Abdullah SF; Mohamad NK; Md Hashim SN; Kishida S; Kishida M; Nakamura N; Kibe T; Harun MH Asian Pac J Cancer Prev; 2020 Apr; 21(4):1005-1009. PubMed ID: 32334462 [TBL] [Abstract][Full Text] [Related]
16. The expression of O(6) -methylguanine-DNA methyltransferase in human oral keratinocytes stimulated with arecoline. Lee SS; Tsai CH; Yu CC; Ho YC; Hsu HI; Chang YC J Oral Pathol Med; 2013 Sep; 42(8):600-5. PubMed ID: 23278137 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of betel quid usage. Gupta PC; Ray CS Ann Acad Med Singap; 2004 Jul; 33(4 Suppl):31-6. PubMed ID: 15389304 [TBL] [Abstract][Full Text] [Related]
18. A preliminary study of arecoline and guvacoline presence in the saliva of a "betel-quid" chewer using liquid-chromatography ion trap mass spectrometry. Kadi AA; Attwa MW; Rahman AF Eur J Mass Spectrom (Chichester); 2013; 19(5):391-7. PubMed ID: 24800422 [TBL] [Abstract][Full Text] [Related]
19. Betel-quid dependence domains and syndrome associated with betel-quid ingredients among chewers: an Asian multi-country evidence. Lee CH; Chiang SL; Ko AM; Hua CH; Tsai MH; Warnakulasuriya S; Ibrahim SO; Sunarjo ; Zain RB; Ling TY; Huang CL; Lane HY; Lin CC; Ko YC Addiction; 2014 Jul; 109(7):1194-204. PubMed ID: 24650227 [TBL] [Abstract][Full Text] [Related]
20. Oral lesions, genotoxicity and nitrosamines in betel quid chewers with no obvious increase in oral cancer risk. Stich HF; Rosin MP; Brunnemann KD Cancer Lett; 1986 Apr; 31(1):15-25. PubMed ID: 3697952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]